Evidence map›Paper›PMID 38942590›Full record

ArticleRMD open2024

Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients.

Ivan Ferraz-Amaro, Fernanda Genre, Ricardo Blanco, Vanesa Calvo-Rio, Cristina Corrales-Selaya, Virginia Portilla, Elena Aurrecoechea, Ricardo Batanero, Vanesa Hernández-Hernández, Juan Carlos Quevedo-Abeledo and 19 more

Abstract readMulticenter Study
In one paragraph

Article in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ivan Ferraz-AmaroServicio de Reumatologia, Hospital Universitario de Canarias, La Laguna, Spain.ORCID 0000-0003-0197-5267
Fernanda GenreGrupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Ricardo BlancoRheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.ORCID 0000-0003-2344-2285
Vanesa Calvo-RioGrupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Cristina Corrales-SelayaGrupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Virginia PortillaHospital Universitario Marques de Valdecilla, Santander, Spain.
Elena AurrecoecheaRheumatology, Hospital Sierrallana, Torrelavega, Spain.
Ricardo BataneroEndocrino, Hospital Universitario Marques de Valdecilla, Santander, Spain.
Vanesa Hernández-HernándezHospital Universitario de Canarias, La Laguna, Spain.
Juan Carlos Quevedo-AbeledoHospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
Carlos Rodríguez-LozanoRheumatology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
Clementina López-MedinaRheumatology, Reina Sofia University Hospital, Cordoba, Spain.ORCID 0000-0002-2309-5837
Lourdes Ladehesa-PinedaUniversity of Cordoba, Cordoba, Spain.
Santos CastañedaRheumatology Department, Hospital Universitario La Princesa, Madrid, Spain.ORCID 0000-0002-7748-853X
Esther F Vicente-RabanedaRheumatology, Hospital de La Princesa, Madrid, Spain.
Cristina Fernández-CarballidoRheumatology, Hospital General Universitario de Elda, Elda, Spain.ORCID 0000-0002-0910-4944
María Paz Martínez VidalHospital General Universitario de Alicante, Alicante, Spain.
David Castro CorredorServicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.ORCID 0000-0001-7315-6274
Joaquín Anino FernándezRheumatology Department, Ciudad Real General Hospital, Ciudad Real, Spain.
Diana PeiteadoHospital Universitario La Paz, Madrid, Spain.
Chamaida Plasencia-RodriguezRheumatology, Hospital Universitario La Paz, Madrid, Spain.ORCID 0000-0003-3503-9047
Rosa ExpósitoHospital Universitario Basurto, Bilbao, Spain.
Maria Luz Garcia VivarDepartment of Rheumatology, Osakidetza Basque Health Service, Basurto University Hospital, Barcelona, Spain.
Eva Galíndez-AgirregoikoaReumatologia, Hospital de Basurto, Basurto, Spain.
Nuria VegasReumatologia, Hospital de Galdakao-Usansolo, Galdakao, Spain.
Irati UrionagüenaRheumatology Division, Hospital Universitario Cruces, Barakaldo, Spain.
Esther Montes-PerezDiagnóstico Médico Cantabria (DMC), Santander, Spain.
Miguel A Gonzalez-Gay *Rheumatology, ISS Fundacion Jimenez Diaz, Madrid, Spain miguelaggay@hotmail.com.ORCID 0000-0002-7924-7406
Javier Rueda-Gotor *Grupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.ORCID 0000-0002-1970-541X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe nature of the relationship between inflammation, cardiovascular (CV) risk factors and atherosclerosis in axial spondyloarthritis (axSpA) remains largely unknown and sex differences in this regard are yet to be assessed.

methodsStudy including 611 men and 302 women from the Spanish multicentre AtheSpAin cohort to assess CV disease in axSpA. Data on CV disease risk factors were collected both at disease diagnosis and at enrolment, and data on disease activity, functional indices and carotid ultrasonography only at enrolment.

resultsAfter a median disease duration of 9 years, patients of both sexes who at disease diagnosis had elevated acute phase reactants (APRs), more frequently had hypertension and obesity. The same occurred with dyslipidaemia in men and with diabetes mellitus in women. At enrolment, CV risk factors were independently associated with APR and with activity and functional indices, with various sex differences. C reactive protein (CRP) values were inversely associated with HDL-cholesterol in men (β coefficient: -1.2 (95% CI: -0.3 to -0.07) mg/dL, p=0.001), while erythrocyte sedimentation rate values were positively associated with triglycerides in women (β coefficient: 0.6 (95% CI: 0.04 to 1) mg/dL, p=0.035). Furthermore, only women showed an independent relationship between insulin resistance parameters and APR or disease activity. Both men and women with high-very high CV risk according to the Systematic Assessment of Coronary Risk Evaluation 2 and CRP levels higher than 3 mg/L at diagnosis of the disease presented carotid plaques significantly more frequently than those with normal CRP levels at disease diagnosis.

conclusionInflammation is associated with atherosclerosis and CV disease in axSpA. A gender-driven effect is observed in this relationship.

Indexed as

AtherosclerosisHeart Disease Risk FactorsInflammationAdultAxial SpondyloarthritisBiomarkersCardiovascular DiseasesC-Reactive ProteinFemaleHumansMaleMiddle AgedRisk FactorsSex FactorsBiomarkersC-Reactive Proteinatherosclerosiscardiovascular diseasesinflammationspondylitis, ankylosing

Identifiers

PMID38942590
PMCPMC11227836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.